Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins

Clinical and Vaccine Immunology

Volumn 13, Issue 4, 2006, Pages 444-451

  Saijo, Masayuki ^a   Niikura, Masahiro ^a,b   Ikegami, Tetsuro ^a,c   Kurane, Ichiro ^a   Kurata, Takeshi ^a   Morikawa, Shigeru ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Michigan State University ^*  (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ANTIGEN DETECTION; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EBOLA VIRUS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FALSE NEGATIVE RESULT; HUMAN; LABORATORY DIAGNOSIS; LASSA FEVER; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; VIRION; VIRUS HEMORRHAGIC FEVER; VIRUS ISOLATION; VIRUS MORPHOLOGY;

ANIMALS; ANTIGENS, VIRAL; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MARBURG VIRUS DISEASE; MARBURGVIRUS; RECOMBINANT PROTEINS;

EID: 33745922387     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.4.444-451.2006     Document Type: Short Survey

References (64)

1. Bausch, D. G., M. Borchert, T. Grein, C. Roth, R. Swanepoel, M. L. Libande, A. Talarmin, E. Bertherat, J. J. Muyembe-Tamfum, B. Tugume, R. Colebunders, K. M. Konde, P. Pirad, L. L. Olinda, G. R. Rodier, P. Campbell, O. Tomori, T. G. Ksiazek, and P. E. Rollin. 2003. Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg. Infect. Dis. 9:1531-1537.
2. Borio, L., T. Inglesby, C. J. Peters, A. L. Schmaljohn, J. M. Hughes, P. B. Jahrling, T. Ksiazek, K. M. Johnson, A. Meyerhoff, T. O'Toole, M. S. Ascher, J. Bartlett, J. G. Breman, E. M. Eitzen, Jr., M. Hamburg, J. Hauer, D. A. Henderson, R. T. Johnson, G. Kwik, M. Layton, S. Lillibridge, G. J. Nabel, M. T. Osterholm, T. M. Perl, P. Russell, and K. Tonat. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405.
3. Bowen, E. T., G. S. Platt, D. I. Simpson, L. B. McArdell, and R. T. Raymond. 1978. Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72:188-191.
4. Bwaka, M. A., M. J. Bonnet, P. Calain, R. Colebunders, A. De Roo, Y. Guimard, K. R. Katwiki, K. Kibadi, M. A. Kipasa, K. J. Kuvula, B. B. Mapanda, M. Massamba, K. D. Mupapa, J. J. Muyembe-Tamfum, E. Ndaberey, C. J. Peters, P. E. Rollin, E. Van den Enden, and E. Van den Enden. 1999. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J. Infect. Dis. 179(Suppl. 1):S1-S7.
5. Centers for Disease Control and Prevention. 1989. Ebola virus infection in imported primates-Virginia, 1989. Morb. Mortal. Wkly. Rep. 38:831-832, 837-838.
6. Centers for Disease Control and Prevention. 1996. Ebola-Reston virus infection among quarantined nonhuman primates-Texas, 1996. Morb. Mortal. Wkly. Rep. 45:314-316.
7. Centers for Disease Control and Prevention. 2001. Outbreak of Ebola hemorrhagic fever-Uganda, August 2000-January 2001. JAMA 285:1010-1012.
8. Conrad, J. L., M. Isaacson, E. B. Smith, H. Wulff, M. Crees, P. Geldenhuys, and J. Johnston. 1978. Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. Am. J. Trop. Med. Hyg. 27:1210-1215.
9. Drosten, C., S. Gottig, S. Schilling, M. Asper, M. Panning, H. Schmitz, and S. Gunther. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 40:2323-2330.
10. Feldmann, H., S. Jones, H. D. Klenk, and H. J. Schnittler. 2003. Ebola virus: from discovery to vaccine. Nat. Rev. Immunol. 3:677-685.
11. Feldmann, H., and M. P. Kiley. 1999. Classification, structure, and replication of filoviruses. Curr. Top. Microbiol. Immunol. 235:1-21.
12. Feldmann, H., W. Slenczka, and H. D. Klenk. 1996. Emerging and reemerging of filoviruses. Arch. Virol. 11(Suppl.):77-100.
13. Feldmann, H., V. E. Volchkov, V. A. Volchkova, U. Stroher, and H. D. Klenk. 2001. Biosynthesis and role of filoviral glycoproteins. J. Gen. Virol. 82:2839-2848.
14. Formenty, P., C. Hatz, B. Le Guenno, A. Stoll, P. Rogenmoser, and A. Widmer. 1999. Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J. Infect. Dis. 179(Suppl. 1):S48-S53.
15. Gear, J. S., G. A. Cassel, A. J. Gear, B. Trappler, L. Clausen, A. M. Meyers, M. C. Kew, T. H. Bothwell, R. Sher, G. B. Miller, J. Schneider, H. J. Koornhof, E. D. Gomperts, M. Isaacson, and J. H. Gear. 1975. Outbreak of Marburg virus disease in Johannesburg. Br. Med. J. iv:489-493.
16. Geisbert, T. W., and P. B. Jahrling. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110-S121.
17. Georges-Courbot, M. C., A. Sanchez, C. Y. Lu, S. Baize, E. Leroy, J. Lansout-Soukate, C. Tevi-Benissan, A. J. Georges, S. G. Trappier, S. R. Zaki, R. Swanepoel, P. A. Leman, P. E. Rollin, C. J. Peters, S. T. Nichol, and T. G. Ksiazek. 1997. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg. Infect. Dis. 3:59-62.
18. Gibb, T. R., D. A. Norwood, Jr., N. Woollen, and E. A. Henchal. 2001. Development and evaluation of a fluorogenic 5′ nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J. Clin. Microbiol. 39:4125-4130.
19. Groen, J., B. G. van den Hoogen, C. P. Burghoorn-Maas, A. R. Fooks, J. Burton, C. J. Clegg, H. Zeller, and A. D. Osterhaus. 2003. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins. Microbes Infect. 5:379-385.
20. Ikegami, T., M. Niikura, M. Saijo, M. E. Miranda, A. B. Calaor, M. Hernandez, L. P. Acosta, D. L. Manalo, I. Kurane, Y. Yoshikawa, and S. Morikawa. 2003. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein. Clin. Diagn. Lab. Immunol. 10:552-557.
21. Ikegami, T., M. Saijo, M. Niikura, M. E. Miranda, A. B. Calaor, M. Hernandez, D. L. Manalo, I. Kurane, Y. Yoshikawa, and S. Morikawa. 2002. Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells. Microbiol. Immunol. 46:633-638.
22. Ikegami, T., M. Saijo, M. Niikura, M. E. Miranda, A. B. Calaor, M. Hernandez, D. L. Manalo, I. Kurane, Y. Yoshikawa, and S. Morikawa. 2003. Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus. Epidemiol. Infect. 130:533-539.
23. Jahrling, P. B., T. W. Geisbert, D. W. Dalgard, E. D. Johnson, T. G. Ksiazek, W. C. Hall, and C. J. Peters. 1990. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335:502-505.
24. Johnson, E. D., B. K. Johnson, D. Silverstein, P. Tukei, T. W. Geisbert, A. N. Sanchez, and P. B. Jahrling. 1996. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol. 11(Suppl.):101-114.
25. Johnson, K. M., L. H. Elliott, and D. L. Heymann. 1981. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. J. Clin. Microbiol. 14:527-529.
26. Johnson, K. M., J. V. Lange, P. A. Webb, and F. A. Murphy. 1977. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet i:569-571.
27. Khan, A. S., F. K. Tshioko, D. L. Heymann, B. Le Guenno, P. Nabeth, B. Kerstiens, Y. Fleerackers, P. H. Kilmarx, G. R. Rodier, O. Nkuku, P. E. Rollin, A. Sanchez, S. R. Zaki, R. Swanepoel, O. Tomori, S. T. Nichol, C. J. Peters, J. J. Muyembe-Tamfum, and T. G. Ksiazek. 1999. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 179(Suppl. 1):S76-S86.
28. Ksiazek, T. G., P. E. Rollin, P. B. Jahrling, E. Johnson, D. W. Dalgard, and C. J. Peters. 1992. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbiol. 30:947-950.
29. Ksiazek, T. G., P. E. Rollin, A. J. Williams, D. S. Bressler, M. L. Martin, R. Swanepoel, F. J. Burt, P. A. Leman, A. S. Khan, A. K. Rowe, R. Mukunu, A. Sanchez, and C. J. Peters. 1999. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179(Suppl. 1):S177-S187.
30. Ksiazek, T. G., C. P. West, P. E. Rollin, P. B. Jahrling, and C. J. Peters. 1999. ELISA for the detection of antibodies to Ebola viruses. J. Infect. Dis. 179(Suppl. 1):S192-S198.
31. Le Guenno, B., P. Formenty, and C. Boesch. 1999. Ebola virus outbreaks in the Ivory Coast and Liberia, 1994-1995. Curr. Top. Microbiol. Immunol. 235:77-84.
32. Leroy, E. M., S. Baize, C. Y. Lu, J. B. McCormick, A. J. Georges, M. C. Georges-Courbot, J. Lansoud-Soukate, and S. P. Fisher-Hoch. 2000. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J. Med. Virol. 60:463-467.
33. Leroy, E. M., B. Kumulungui, X. Pourrut, P. Rouquet, A. Hassanin, P. Yaba, A. Delicat, J. T. Paweska, J. P. Gonzalez, and R. Swanepoel. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575-576.
34. Lucht, A., R. Grunow, P. Moller, H. Feldmann, and S. Becker. 2003. Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. J. Virol. Methods 111:21-28.
35. Lucht, A., R. Grunow, C. Otterbein, P. Moller, H. Feldmann, and S. Becker. 2004. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med. Microbiol. Immunol. (Berlin) 193:181-187.
36. Martini, G. A., H. G. Knauff, H. A. Schmidt, G. Mayer, and G. Baltzer. 1968. On the hitherto unknown, in monkeys originating infectious disease: Marburg virus disease. Dtsch. Med. Wochenschr. 93:559-571.
37. Meissner, F., T. Maruyama, M. Frentsch, A. J. Hessell, L. L. Rodriguez, T. W. Geisbert, P. B. Jahrling, D. R. Burton, and P. W. Parren. 2002. Detection of antibodies against the four subtypes of Ebola virus in sera from any species using a novel antibody-phage indicator assay. Virology 300:236-243.
38. Niedrig, M., H. Schmitz, S. Becker, S. Gunther, J. ter Meulen, H. Meyer, H. Ellerbrok, A. Nitsche, H. R. Gelderblom, and C. Drosten. 2004. First international quality assurance study on the rapid detection of viral agents of bioterrorism. J. Clin. Microbiol. 42:1753-1755.
39. Niikura, M., T. Ikegami, M. Saijo, I. Kurane, M. E. Miranda, and S. Morikawa. 2001. Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. J. Clin. Microbiol. 39:3267-3271.
40. Niikura, M., T. Ikegami, M. Saijo, T. Kurata, I. Kurane, and S. Morikawa. 2003. Analysis of linear B-cell epitopes of the nucleoprotein of Ebola virus that distinguish Ebola virus subtypes. Clin. Diagn. Lab. Immunol. 10:83-87.
41. Okome-Nkoumou, M., and M. Kombila. 1999. A case of Ebola virus hemorrhagic fever in Libreville (Gabon), fatal after evacuation to South Africa. Med. Trop. (Mars) 59:411.
42. Peters, C. J., and J. W. LeDuc. 1999. An introduction to Ebola: the virus and the disease. J. Infect. Dis. 179(Suppl. 1):ix-xvi.
43. Prehaud, C., E. Hellebrand, D. Coudrier, V. E. Volchkov, V. A. Volchkova, H. Feldmann, B. Le Guenno, and M. Bouloy. 1998. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J. Gen. Virol. 79:2565-2572.
44. Saijo, M., M. Niikura, A. Maeda, T. Sata, T. Kurata, I. Kurane, and S. Morikawa. 2005. Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP-capture enzyme-linked immunosorbent assay. J. Med. Virol. 76:111-118.
45. Saijo, M., M. Niikura, S. Morikawa, T. G. Ksiazek, R. F. Meyer, C. J. Peters, and I. Kurane. 2001. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J. Clin. Microbiol. 39:1-7.
46. Saijo, M., M. Niikura, S. Morikawa, and I. Kurane. 2001. Immunofluorescence method for detection of Ebola virus immunoglobulin G, using HeLa cells which express recombinant nucleoprotein. J. Clin. Microbiol. 39:776-778.
47. Sanchez, A., A. S. Khan, S. Zaki, G. J. Nabel, T. G. Ksiazek, and C. J. Peters. 2001. Filoviridae: Marburg and Ebola viruses, p. 1279-1304. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
48. Sanchez, A., T. G. Ksiazek, P. E. Rollin, M. E. Miranda, S. G. Trappier, A. S. Khan, C. J. Peters, and S. T. Nichol. 1999. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J. Infect. Dis. 179(Suppl. 1):S164-S169.
49. Smith, D. H., B. K. Johnson, M. Isaacson, R. Swanapoel, K. M. Johnson, M. Killey, A. Bagshawe, T. Siongok, and W. K. Keruga. 1982. Marburg-virus disease in Kenya. Lancet i:816-820.
50. Towner, J. S., P. E. Rollin, D. G. Bausch, A. Sanchez, S. M. Crary, M. Vincent, W. F. Lee, C. F. Spiropoulou, T. G. Ksiazek, M. Lukwiya, F. Kaducu, R. Downing, and S. T. Nichol. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J. Virol. 78:4330-4341.
51. van der Groen, G., T. Kurata, and C. Mets. 1983. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material. Lancet i:654.
52. Volchkov, V., V. Volchkova, C. Eckel, H. D. Klenk, M. Bouloy, B. LeGuenno, and H. Feldmann. 1997. Emergence of subtype Zaire Ebola virus in Gabon. Virology 232:139-144.
53. Weidmann, M., E. Muhlberger, and F. T. Hufert. 2004. Rapid detection protocol for filoviruses. J. Clin. Virol. 30:94-99.
54. World Health Organization. 1978. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull. W. H. O. 56:247-270.
55. World Health Organization. 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull. W. H. O. 56:271-293.
56. World Health Organization. 2005. Marburg haemorrhagic fever, Angola. Wkly. Epidemiol. Rec. 80:158-159.
57. World Health Organization. 1996. Outbreak of Ebola haemorrhagic fever in Gabon. Commun. Dis. Rep. CDR Wkly. 6:75, 78.
58. World Health Organization. 2001. Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001. Wkly. Epidemiol. Rec. 76:41-46.
59. World Health Organization. 1995. Outbreak of Ebola hemorrhagic fever-Zaire, 1995. Epidemiol. Bull. 16:16.
60. World Health Organization. 2005. Outbreak of Marburg virus hemorrhagic fever-Angola, October 1, 2004-March 29, 2005. Morb. Mortal. Wkly. Rep. 54:308-309.
61. World Health Organization. 2003. Outbreak(s) of Ebola haemorrhagic fever in the Republic of the Congo, January-April 2003. Wkly. Epidemiol. Rec. 78:285-289.
62. World Health Organization. 2003. Outbreak(s) of Ebola hemorrhagic fever, Congo and Gabon, October 2001 to July 2002. Can. Commun. Dis. Rep. 29:129-133.
63. World Health Organization. 1992. Viral haemorrhagic fever in imported monkeys. Wkly. Epidemiol. Rec. 67:142-143.
64. Zaki, S. R., W. J. Shieh, P. W. Greer, C. S. Goldsmith, T. Ferebee, J. Katshitshi, F. K. Tshioko, M. A. Bwaka, R. Swanepoel, P. Calain, A. S. Khan, E. Lloyd, P. E. Rollin, T. G. Ksiazek, and C. J. Peters. 1999. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 179 (Suppl. 1):S36-S47.